Literature DB >> 2883488

Doxycycline prophylaxis for falciparum malaria.

L W Pang, N Limsomwong, E F Boudreau, P Singharaj.   

Abstract

188 schoolchildren aged 10-15 living in a malaria endemic area along the Thai-Burmese border were matched for age, splenomegaly, and weight and were then randomly assigned to receive either doxycycline (adult equivalent of 100 mg daily) or chloroquine (adult equivalent of 300 mg base weekly). All drugs were administered by the investigators and blood smears were done weekly. In 95 subjects taking doxycycline for 597 man-weeks there were 5 cases of falciparum malaria and in the 93 controls taking chloroquine for 488 man-weeks there were 31. Doxycycline was more effective than chloroquine in the prevention of falciparum malaria infections (p less than 0.0001). The doxycycline group did not have significantly more side-effects than the chloroquine group.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2883488     DOI: 10.1016/s0140-6736(87)92141-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  21 in total

Review 1.  Compliance in clinical trials.

Authors:  T Pullar; S Kumar; M Feely
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

Review 2.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

Review 3.  Prevention of malaria in travellers: a growing problem.

Authors:  J S Keystone; J D MacLean
Journal:  CMAJ       Date:  1989-11-15       Impact factor: 8.262

Review 4.  Antimalarial agents: specific chemoprophylaxis regimens.

Authors:  B L Herwaldt; D J Krogstad; P H Schlesinger
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

Review 5.  Toxicity of antimalarial drugs.

Authors:  T E Peto
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

6.  Malaria prophylaxis with proguanil and sulfisoxazole in children living in a malaria endemic area.

Authors:  L W Pang; N Limsomwong; P Singharaj; C J Canfield
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

Review 7.  Adverse effects of antimalarials. An update.

Authors:  G A Luzzi; T E Peto
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

8.  In vitro and in vivo effects of doxycycline on Toxoplasma gondii.

Authors:  H R Chang; R Comte; J C Pechère
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

Review 9.  Human antiprotozoal therapy: past, present, and future.

Authors:  M Khaw; C B Panosian
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

10.  Multinormal in vitro distribution model suitable for the distribution of Plasmodium falciparum chemosusceptibility to doxycycline.

Authors:  Sébastien Briolant; Meili Baragatti; Philippe Parola; Fabrice Simon; Adama Tall; Cheikh Sokhna; Philippe Hovette; Modeste Mabika Mamfoumbi; Jean-Louis Koeck; Jean Delmont; André Spiegel; Jacky Castello; Jean Pierre Gardair; Jean Francois Trape; Maryvonne Kombila; Philippe Minodier; Thierry Fusai; Christophe Rogier; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2008-12-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.